Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC

Clinical trial NCT05380271 · UNKNOWN

Trial details

NCT number: NCT05380271
Sponsor: Gang Wu
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung

Start date: 2022-07-01
Primary completion: 2022-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.